MissionIR Articles
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Request to Continue Listing Is Granted by NASDAQ Hearings Panel
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was notified by the NASDAQ Hearings Panel that its request to continue listing on the NASDAQ capital market has been granted with two conditions. Those conditions call for the company to maintain a closing bid price of $1 per share for 20 consecutive trading sessions…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Selected by Leading Pharmaceutical Giant for Vital Logistics Operation
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning and providing a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region. The company today announced a significant achievement with the recent success of securing an RFQ (Request for…
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Brings Sustainable Solution for Rising Demand in ‘Rattiest Cities’
A recent Fox Business article discussed pest control company Orkin’s annual ranking of the “Top 50 Rattiest Cities,” where Chicago continues to top the list, followed by Los Angeles, New York City, Washington, D.C., and San Francisco. Rankings are based on the number of new rodent services showcasing the demand and efforts that residents and…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Schedules Q3 2023 Earnings Call
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, has announced plans to report on its third-quarter financial results for the period ended Sept. 30, 2023. The company will issue its third quarter earnings press release before market opens on Nov. 9, 2023. In addition, D-Wave Quantum CEO Alan Baratz and…
-
MissionIRNewsBreaks – Safety Shot (NASDAQ: SHOT) Granted Second U.S. Patent for JW-700 Treatment Designed for $1.5B Hair-Growth Market
Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, announced a “significant milestone” in its development of treatments for androgenetic alopecia, or hair loss: the granting of a second U.S. patent issued for JW-700, a topical treatment designed to improve minoxidil’s efficacy. The patent was issued by the U.S. Patent and Trademark Office. The…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private Placement, Preferred Investment Options
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, has entered into a definitive agreement for the issue and sale of more than 3 million common shares, or prefunded warrants in lieu thereof. Specifically, the company agreed to a private placement of 3,012,049 common…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced its selection of a lead Alzheimer’s disease drug candidate, named INM-901, following positive results from several proof-of-concept studies in a validated Alzheimer’s treatment model. InMed will be advancing cannabinoid analog INM-901 in its…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Update on Progress of Action Filed Against Key Broker Dealers
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on the status of the lawsuit it filed against TD Ameritrade, Charles Schwab, National Finance Services and others alleging that those broker dealers engaged in a scheme to manipulate the share price of the company’s securities. Mullen filed the lawsuit in August 2023…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Committed to R&D, Eyeing Excellent Opportunities
Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator seeking to enhance the bioavailability of multiple active pharmaceutical ingredients using its patented DehydraTECH(TM) drug delivery technology platform. The company continues to devote an increasing proportion of its resources and focus toward research and development (“R&D”) as part of its overall goal to establish areas of…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Drive Toward Potential New GBM Treatment
CNS Pharmaceuticals (NASDAQ: CNSP) recently announced rapid enrollment in its potentially pivotal study involving its flagship drug candidate, Berubicin, and is moving closer to reporting the results of its drive toward a new treatment for the effectively incurable brain cancer glioblastoma (“GBM”). “The Texas-based company has clinical trial sites operating in the U.S., Italy, France,…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Filing of Federal Lawsuit Against Research Firm
FingerMotion (NASDAQ: FNGR), a mobile services and data company, has filed a federal lawsuit against Capybara Research; the lawsuit alleges that Capybara maliciously published a defamatory article in a premediated attempt to move the public market for FingerMotion’s stock lower to benefit from its previously announced short position. FingerMotion filed the complaint in the United…
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Featured in Virtual Webcast at Lytham Partners Fall 2023 Investor Conference
SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, presented virtually in a webcast presentation as part of of the Lytham Partners Fall 2023 Investor Conference. The company’s president and CEO Joel Fruendt and CFO Tom Chesterman joined Lytham Partners Managing Partner Robert Blum…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Announces Participation at Upcoming Virtual Investor Ask the CEO Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured at this month’s Virtual Investor Ask the CEO Conference. CNS Pharmaceuticals CEO John Climaco is scheduled to participate in a live moderated webcast during the conference;…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Filing of Preliminary Proxy Statement
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has filed a preliminary proxy statement with the Securities and Exchange Commission (the “SEC”) regarding a special stockholders’ meeting to be held on Dec. 15, 2023, to authorize Mullen’s board of directors to effect a reverse stock split of the company’s…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Launches New Open-Source Demo Highlighting Quantum System’s Ability to Improve Cellphone Network Transmission
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, has released a new open-source demonstration that highlights how the company’s Advantage(TM) annealing quantum computing system can be used to tackle wireless channel decoding. Available in the Leap(TM) real-time quantum cloud service from…
-
MissionIRNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Featured in Bell2Bell Podcast
PaxMedica (NASDAQ: PXMD), a prominent clinical-stage biopharmaceutical firm, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. PaxMedica’s CEO and Chairman Howard Weisman and Buzz Woods, from the company’s corporate communications department, joined the program to offer a compelling…
-
MissionIRNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Strengthen Position in Alternative Mental-Health Treatments Sector
Lucy Scientific Discovery (NASDAQ: LSDI), a pioneer in alternative mental-health treatments, is working to provide ingredients for effective mental-health treatment and therapies, including psilocybin and MDMA. According to a recent article spotlighting LSDI, the company is “well positioned” to support the mental-health space as it continues to grow. The article noted that mental-health issues are…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) ‘Innovates’ Investigational Drug with Patented Nanotechnology
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, announced that it has innovated its investigational drug, CNM-Au8(R), with nanotechnology. Clene is evaluating CNM-Au8(R) for the treatment of neurodegenerative disease, and the innovation reflects the growing importance of nanotechnology in the drug space.…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Files NI 43-101 Iska Iska Technical Report
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine-development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, has filed a National Instrument 43-101 (“NI 43-101”) Technical Report. According to the announcement, the report is in support of the initial mineral resource estimate (“MRE”) for the Iska Iska…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) ‘Strikingly Different’ Road Tour Lands at Sonoma Motor Speedway
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is seeing a striking response to its Strikingly Different road tour, which is designed to offer potential customers and other interested individuals an opportunity to directly interact with its vehicles. The tour’s next stop is scheduled on Oct. 23–24, 2023, at the Sonoma Motor Speedway.…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Strengthens Position amid Global REE Supply Challenges
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Partners With Demora Foundation To Power K-Entertainment Tokenization Platform
- MissionIRNewsBreaks – CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Explores Multi-Vein Potential at Idaho Clayton Project
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Reports 2025 Results, Expands Margins Amid Strategic Shift